Login / Signup

Clinical considerations for estrogen receptor-negative/progesterone receptor-positive/HER2-negative (ER - PR + HER2 - ) breast cancer.

Bruno Henrique Rala de PaulaSusanne CrocamoJose Bines
Published in: Translational breast cancer research : a journal focusing on translational research in breast cancer (2022)
Keyphrases
  • estrogen receptor
  • young adults
  • binding protein